Canada Markets closed

Caladrius Biosciences, Inc. (CLBS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9000-0.0377 (-4.02%)
At close: 04:00PM EST
0.9450 +0.05 (+5.00%)
After hours: 05:56PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.8900
52 Week Low 30.8850
50-Day Moving Average 31.1222
200-Day Moving Average 31.4591

Share Statistics

Avg Vol (3 month) 3346.37k
Avg Vol (10 day) 3453.03k
Shares Outstanding 559.5M
Implied Shares Outstanding 6N/A
Float 846.11M
% Held by Insiders 13.18%
% Held by Institutions 129.18%
Shares Short (May 27, 2021) 41.48M
Short Ratio (May 27, 2021) 42.44
Short % of Float (May 27, 2021) 42.51%
Short % of Shares Outstanding (May 27, 2021) 42.48%
Shares Short (prior month Apr. 29, 2021) 41.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul. 27, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul. 27, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.18%
Return on Equity (ttm)-19.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.11M
Net Income Avi to Common (ttm)-12.22M
Diluted EPS (ttm)-0.5240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111.51M
Total Cash Per Share (mrq)1.87
Total Debt (mrq)536k
Total Debt/Equity (mrq)0.49
Current Ratio (mrq)25.69
Book Value Per Share (mrq)1.85

Cash Flow Statement

Operating Cash Flow (ttm)-12.56M
Levered Free Cash Flow (ttm)-15.46M